These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30120476)

  • 21. A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting.
    Wallerstein R; Jelks A; Garabedian MJ
    J Pregnancy; 2014; 2014():962720. PubMed ID: 25101177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis.
    Di Mascio D; Khalil A; Rizzo G; Buca D; Liberati M; Martellucci CA; Flacco ME; Manzoli L; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):647-655. PubMed ID: 32632979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis.
    Judah H; Gil MM; Syngelaki A; Galeva S; Jani J; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):178-189. PubMed ID: 33838069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical Research Council European trial of chorion villus sampling. MRC working party on the evaluation pf chorion villus sampling.
    Lancet; 1991 Jun; 337(8756):1491-9. PubMed ID: 1675367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free DNA analysis for noninvasive examination of trisomy.
    Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
    N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
    Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
    BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008.
    Morris JK; Waters JJ; de Souza E
    Prenat Diagn; 2012 Jun; 32(6):596-601. PubMed ID: 22573430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study.
    Hsu WW; Hsieh CJ; Lee CN; Chen CL; Lin MW; Kang J; Tai YY; Huang KY; Lin SY
    J Formos Med Assoc; 2019 Jul; 118(7):1107-1113. PubMed ID: 30928186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
    Akolekar R; Beta J; Picciarelli G; Ogilvie C; D'Antonio F
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):16-26. PubMed ID: 25042845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive view and increased likely uptake of follow-up testing with analysis of cell-free fetal DNA as alternative to invasive testing among Danish pregnant women.
    Miltoft CB; Rode L; Tabor A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):577-586. PubMed ID: 29350746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial.
    Philip J; Silver RK; Wilson RD; Thom EA; Zachary JM; Mohide P; Mahoney MJ; Simpson JL; Platt LD; Pergament E; Hershey D; Filkins K; Johnson A; Shulman LP; Bang J; MacGregor S; Smith JR; Shaw D; Wapner RJ; Jackson LG;
    Obstet Gynecol; 2004 Jun; 103(6):1164-73. PubMed ID: 15172848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice.
    Scott F; Peters H; Boogert T; Robertson R; Anderson J; McLennan A; Kesby G; Edelman D
    Aust N Z J Obstet Gynaecol; 2002 Feb; 42(1):55-8. PubMed ID: 11926642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
    Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
    N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.